Findings

What do systematic reviews say?

3 questions · 6 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 2 · 33.3%Low 4 · 66.7%Moderate 0 · 0%High 0 · 0%

Closest answers

The findings closest to your search, judged one by one by TypeSafe's Jev model.

Related · question page
- FXIII: Prophylactic trials: intervention vs inactive control · Venous thromboembolic events ‐ Up to 5 to 7 weeks post‐operatively
  Pro‐coagulant haemostatic factors for the prevention and treatment of bleeding in people without haemophilia 2018 · Cochrane Headline outcomes only
  RR 0.93 [0.06, 14.67]
  2 studies · 282 participants
  Low
Related · question page
- FXIII: Prophylactic trials: intervention vs inactive control · Arterial thromboembolic events Up to 5 to 7 weeks post‐operatively
  Pro‐coagulant haemostatic factors for the prevention and treatment of bleeding in people without haemophilia 2018 · Cochrane Headline outcomes only
  RR 0.67 [0.28, 1.62]
  2 studies · 282 participants
  Low
Related · question page
- FXIII: Prophylactic trials: intervention vs inactive control · Venous thromboembolic events Up to 30 days post‐operatively
  Pro‐coagulant haemostatic factors for the prevention and treatment of bleeding in people without haemophilia 2018 · Cochrane Headline outcomes only
  RR 3 [0.14, 66.53]
  1 study · 22 participants
  Low

FXIII: Prophylactic trials: intervention vs inactive control

Arterial thromboembolic events Post‐operatively · the prevention and treatment of bleeding in patients without haemophilia

FXIII: Prophylactic trials: intervention showed no clear difference in arterial thromboembolic events Up to 5 to 7 weeks post‐operatively compared with inactive control (low certainty).

3 findings from 1 review

Pro‐coagulant haemostatic factors for the prevention and treatment of bleeding in people without haemophilia 2018 · Cochrane Headline outcomes only
RR 0.67 [0.28, 1.62]
2 studies · 282 participants
Low
Pro‐coagulant haemostatic factors for the prevention and treatment of bleeding in people without haemophilia 2018 · Cochrane Headline outcomes only
RR 3 [0.14, 66.53]
1 study · 22 participants
Low
Pro‐coagulant haemostatic factors for the prevention and treatment of bleeding in people without haemophilia 2018 · Cochrane Headline outcomes only
RR 0.2 [0.01, 3.97]
1 study · 50 participants
Very low

FXIII: Prophylactic trials: intervention vs inactive control

Venous thromboembolic events · the prevention and treatment of bleeding in patients without haemophilia

FXIII: Prophylactic trials: intervention showed no clear difference in venous thromboembolic events ‐ Up to 5 to 7 weeks post‐operatively compared with inactive control (low certainty).

2 findings from 1 review

Pro‐coagulant haemostatic factors for the prevention and treatment of bleeding in people without haemophilia 2018 · Cochrane Headline outcomes only
RR 0.93 [0.06, 14.67]
2 studies · 282 participants
Low
Pro‐coagulant haemostatic factors for the prevention and treatment of bleeding in people without haemophilia 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 50 participants
Very low

FXIII: Prophylactic trials: intervention vs inactive control

Venous thromboembolic events Up to 30 days post‐operatively · the prevention and treatment of bleeding in patients without haemophilia

FXIII: Prophylactic trials: intervention showed no clear difference in venous thromboembolic events Up to 30 days post‐operatively compared with inactive control (low certainty).

1 finding from 1 review

Pro‐coagulant haemostatic factors for the prevention and treatment of bleeding in people without haemophilia 2018 · Cochrane Headline outcomes only
RR 3 [0.14, 66.53]
1 study · 22 participants
Low